Zobrazeno 1 - 10
of 22
pro vyhledávání: '"E L, Ramos"'
Autor:
E L Ramos
Publikováno v:
Seminars in Dialysis. 8:23-28
Autor:
E L Ramos, E Tomlanovich, Timo Paavonen, E Taskinen, L Hooftman, E Aavik, S Yilmaz, M Navarro, T Mathew, Pekka Häyry, J Vamvakopoulos
Publikováno v:
Transplantation Proceedings. 36:89-91
Following encouraging results from several single-center studies showing that early histological manifestations of chronic rejection are seen in the graft before a decline in transplant function, we tested this concept in a multicenter study and inve
Autor:
Margaret J. Bia, K J Murphy, P A Bowen, Bertram L. Kasiske, Robert S. Gaston, E L Ramos, Gabriel M. Danovitch, P A Lundin
Publikováno v:
Journal of the American Society of Nephrology. 6:1-34
Autor:
John C. Peterson, E L Ramos, Yousri M. Barri, Byron P. Croker, Christopher S. Wilcox, William L. Clapp
Publikováno v:
Transplantation. 59:490-494
Thromboxane synthase (TS) catalyzes the formation of thromboxane (TxA 2 ) in monocytes/macrophages, platelets, and various tissues. TxA 2 is likely to play a role in graft dysfunction due to its vasoconstrictive and platelet aggregatory properties. W
Autor:
Lawrence Kahana, Steven R. Alexander, Gabriel M. Danovitch, William E. Harmon, Bertram L. Kasiske, John F. Neylan, Thomas J. Kiresuk, E L Ramos
Publikováno v:
Transplantation. 57:490-497
The criteria for acceptance of candidates for renal transplantation varies throughout the United States. The Patient Care and Education Committee of the American Society of Transplant Physicians conducted a survey of all U.S. centers that participate
Autor:
E L Ramos
Publikováno v:
Journal of the American Society of Nephrology. 2:109-121
Although recurrent diseases in the renal transplant are becoming increasing recognized as graft survival continue to improve, they account for less than 2 to 4% of all allograft failures. The most frequent cause of recurrent disease is recurrent glom
Autor:
Timo Paavonen, Steven Tomlanovich, E L Ramos, Pekka Häyry, Timothy Mathew, Merci Navarro, Eero Taskinen, Leon Hooftman, Serdar Yilmaz
Publikováno v:
Journal of the American Society of Nephrology : JASN. 14(3)
This study is an investigation of whether a protocol biopsy may be used as surrogate to late graft survival in multicenter renal transplantation trials. During two mycophenolate mofetil trials, 621 representative protocol biopsies were obtained at ba
Publikováno v:
Transplantation proceedings. 28(2)
Publikováno v:
Clinical transplantation. 10(1 Pt 1)
While H2-receptor antagonists are commonly used in renal transplant patients to prevent peptic ulcer disease, they have been associated with immunostimulation, interference with cyclosporine (CsA) metabolism, and inhibition of tubular secretion of cr
Autor:
Christopher S. Wilcox, E L Ramos, Eva A. Berkes, John C. Peterson, Byron P. Croker, Yousri M. Barri
Publikováno v:
Kidney international. 48(4)
Thromboxane synthase (TS) catalyzes the formation of the eicosanoid thromboxane (TxA 2 ), which is a potent vasoconstrictor and activator of platelet aggregation. It has a widespread distribution, including hemopoietic cells (platelets, macrophages,